MedTrace Logo

Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma

NCT06256458 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-02-12

No results posted yet for this study

Summary

This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.

Conditions

  • Fractures, Bone

Interventions

DEVICE

NanoBone® Bone Graft

The surgical technique used by the surgeon and the choice of the specific NanoBone product is or was determined solely by the surgeon and is independent of this observational study.

Sponsors & Collaborators

  • Artoss Inc.

    lead INDUSTRY

Principal Investigators

  • Mitchell D Kuhl, DO · SSM Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2026-12-01
Completion
2026-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06256458 on ClinicalTrials.gov